Publications by authors named "Mascha Mayer"

Claim this Profile
P
Preclinical Efficacy and Toxicity Analysis of the Pan-Histone Deacetylase Inhibitor Gossypol for the Therapy of Colorectal Cancer or Hepatocellular Carcinoma.
Mascha Mayer, Alexander Berger, Christian Leischner, Olga Renner, Markus Burkard

Pharmaceuticals (Basel)· April 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Systematic Review of Gossypol/AT-101 in Cancer Clinical Trials.
Olga Renner, Mascha Mayer, Christian Leischner, Markus Burkard, Alexander Berger

Pharmaceuticals (Basel)· January 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Resveratrol as a pan-HDAC inhibitor alters the acetylation status of histone [corrected] proteins in human-derived hepatoblastoma cells.
Sascha Venturelli, Alexander Berger, Alexander Böcker, Christian Busch, Timo Weiland, Mascha Mayer

PLoS One· April 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis